Proposal of a clinical care pathway for quality and safe management of headache patients: a consensus study report.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
30 10 2020
Historique:
entrez: 31 10 2020
pubmed: 1 11 2020
medline: 15 5 2021
Statut: epublish

Résumé

Headache is one of the most prevalent and disabling conditions. Its optimal management requires a coordinated and comprehensive response by health systems, but there is still a wide variability that compromises the quality and safety of the care process. To establish the basis for designing a care pathway for headache patients through identifying key subpathways in the care process and setting out quality and clinical safety standards that contribute to providing comprehensive, adequate and safe healthcare. A qualitative research study based on the consensus conference technique. Eleven professionals from the Spanish National Health System participated, seven of them with clinical experience in headache and four specialists in healthcare management and quality. First, identification of the key subpathways in the care process for headache, barriers/limitations for optimal quality of care, and quality and safety standards applied in each subpathway. Second, two consecutive consensus rounds were carried out to assess the content of the subpathway level descriptors, until the expert agreement was reached. Third, findings were assessed by 17 external healthcare professionals to determine their understanding, adequacy and usefulness. Seven key subpathways were identified: (1) primary care, (2) emergency department, (3) neurology department, (4) specialised headache unit, (5) hospitalisation, (6) outpatients and (7) governance and management. Sixty-seventh barriers were identified, the most frequent being related to diagnostic errors (36,1%), resource deficiency (25%), treatment errors (19,4%), lack of health literacy (13,9%) and inadequate communications with care transitions (5,6%). Fifty-nine quality and 31 safety standards were defined. They were related to evaluation (23.3%), patient safety (21.1%), comprehensive care (12.2%), treatment (12.2%), clinical practice guidelines (7.8%), counselling (6.7%), training (4.4%) and patient satisfaction (3.3%). This proposal incorporates a set of indicators and standards, which can be used to define a pathway for headache patients and determine the levels of quality.

Sections du résumé

BACKGROUND
Headache is one of the most prevalent and disabling conditions. Its optimal management requires a coordinated and comprehensive response by health systems, but there is still a wide variability that compromises the quality and safety of the care process.
PURPOSE
To establish the basis for designing a care pathway for headache patients through identifying key subpathways in the care process and setting out quality and clinical safety standards that contribute to providing comprehensive, adequate and safe healthcare.
METHOD
A qualitative research study based on the consensus conference technique. Eleven professionals from the Spanish National Health System participated, seven of them with clinical experience in headache and four specialists in healthcare management and quality. First, identification of the key subpathways in the care process for headache, barriers/limitations for optimal quality of care, and quality and safety standards applied in each subpathway. Second, two consecutive consensus rounds were carried out to assess the content of the subpathway level descriptors, until the expert agreement was reached. Third, findings were assessed by 17 external healthcare professionals to determine their understanding, adequacy and usefulness.
RESULTS
Seven key subpathways were identified: (1) primary care, (2) emergency department, (3) neurology department, (4) specialised headache unit, (5) hospitalisation, (6) outpatients and (7) governance and management. Sixty-seventh barriers were identified, the most frequent being related to diagnostic errors (36,1%), resource deficiency (25%), treatment errors (19,4%), lack of health literacy (13,9%) and inadequate communications with care transitions (5,6%). Fifty-nine quality and 31 safety standards were defined. They were related to evaluation (23.3%), patient safety (21.1%), comprehensive care (12.2%), treatment (12.2%), clinical practice guidelines (7.8%), counselling (6.7%), training (4.4%) and patient satisfaction (3.3%).
CONCLUSIONS
This proposal incorporates a set of indicators and standards, which can be used to define a pathway for headache patients and determine the levels of quality.

Identifiants

pubmed: 33127628
pii: bmjopen-2020-037190
doi: 10.1136/bmjopen-2020-037190
pmc: PMC7604819
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e037190

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: This study has been sponsored by Novartis, but no laboratory professional has been involved in the design of the work, recruitment of professionals, data collection and analysis, or in the interpretation of the results. The authors of the paper have developed the entire process of execution of the study independently.

Références

Neurologia. 2010 Mar;25(2):104-7
pubmed: 20487710
Rev Neurol. 2019 Jun 16;68(12):510-516
pubmed: 31173331
Neurologia. 2020 Jul 25;:
pubmed: 32718873
J Headache Pain. 2016 Dec;17(1):111
pubmed: 27933580
Neurologia. 2011 Jan-Feb;26(1):39-44
pubmed: 21163210
BMJ. 1995 Aug 5;311(7001):376-80
pubmed: 7640549
J Headache Pain. 2015;16:537
pubmed: 26059349
J Headache Pain. 2019 Mar 4;20(1):24
pubmed: 30832585
Rev Neurol. 2016 Jun 16;62(12):549-54
pubmed: 27270676
Rev Neurol. 2012 Nov 16;55(10):577-84
pubmed: 23143958
J Headache Pain. 2017 Dec;18(1):55
pubmed: 28477307
Neurologia. 2018 Jul 30;:
pubmed: 30072273
J Headache Pain. 2019 Jun 25;20(1):73
pubmed: 31238877
Rev Neurol. 2010 May 16;50(10):577-83
pubmed: 20473832
Neurologia. 2020 Apr;35(3):176-184
pubmed: 28870393
Cochrane Database Syst Rev. 2018 Jun 25;6:CD011616
pubmed: 29939406
Plast Reconstr Surg. 2019 Jan;143(1):239-250
pubmed: 30589800
J Headache Pain. 2010 Aug;11(4):289-99
pubmed: 20473702
J Headache Pain. 2012 Aug;13(6):449-57
pubmed: 22733141
Lancet. 2019 Nov 9;394(10210):1765-1774
pubmed: 31668411
J Headache Pain. 2012 Aug;13(6):437-47
pubmed: 22736100
J Headache Pain. 2011 Aug;12(4):419-26
pubmed: 21380555
Nurse Res. 2008;16(1):56-71
pubmed: 19025106
J Headache Pain. 2018 Sep 10;19(1):82
pubmed: 30203163
Rev Neurol. 1998 Nov;27(159):750-4
pubmed: 9859144
Lancet Neurol. 2004 Apr;3(4):204-5
pubmed: 15039030

Auteurs

Julio Pascual (J)

Service of Neurology, University Hospital Marqués de Valdecilla and Valdecilla Biomedical Research Institute, Santander, Cantabria, Spain.
Department of Medicine, University of Cantabria, Santander, Cantabria, Spain.

Patricia Pozo-Rosich (P)

Headache Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Catalonia, Spain.
Headache Research Group, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.

Irene Carrillo (I)

Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), Sant Joan d'Alacant, Valencia Region, Spain icarrillo@umh.es.
Department of Health Psychology, Miguel Hernández University, Elche, Valencia Region, Spain.

Sandra Rodríguez-Justo (S)

Emergency Department, Complejo Hospitalario de Vigo, Vigo, Galicia, Spain.

Dolores Jiménez-Hernández (D)

Neurology Department, Virgen del Rocío University Hospital, Seville, Andalusia, Spain.
Faculty of Medicine, University of Seville, Seville, Andalusia, Spain.

Almudena Layos-Romero (A)

Headache Unit, Neurology Department, University Hospital of Albacete, Albacete, Castile-La Mancha, Spain.

Cristina Bailón-Santamaría (C)

Service of Neurology, University Hospital Marqués de Valdecilla and Valdecilla Biomedical Research Institute, Santander, Cantabria, Spain.

Antonio Torres (A)

Andalusian Agency for Healthcare Quality, Seville, Andalusia, Spain.

Alba Martínez-García (A)

Department of Health Psychology, Miguel Hernández University, Elche, Valencia Region, Spain.

Emilio Ignacio (E)

Department of Nursing and Physiotherapy, University of Cadiz, Cadiz, Andalusia, Spain.

José Joaquín Mira (JJ)

Department of Health Psychology, Miguel Hernández University, Elche, Valencia Region, Spain.
Alicante-Sant Joan Health District, Alicante, Valencia Region, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH